Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$21.23 -0.15 (-0.70%)
At close: Nov 16, 2026 · 4:00 PM EST

Amneal Pharmaceuticals (AMRX) Net Shares Issued and Repurchased (2018 - 2026)

Updated

Amneal Pharmaceuticals' Net Shares Issued and Repurchased was $436,000 in Q3 2026, down 33.2% from $653,000 a year earlier but up 938.1% from the prior quarter.

Analysis

Amneal Pharmaceuticals (AMRX) Net Shares Issued and Repurchased (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, Amneal Pharmaceuticals' Net Shares Issued and Repurchased was $1.07 million through Sep 30, 2026, down 31.4% year-over-year; for FY2025, it was $1.96 million, up 69.8% from FY2024.

  • Net Shares Issued and Repurchased shows a five-year compound annual growth rate of 43.6% (FY2020 to FY2025).
  • In earlier years, Net Shares Issued and Repurchased was $1.15 million in FY2024 (+155.9%), $451,000 in FY2023 (-31.9%), $662,000 in FY2022 (-22.4%) and $853,000 in FY2021 (+165.7%).
  • Quarterly Net Shares Issued and Repurchased has moved between $19,000 (Q4 2021) and $685,000 (Q2 2025) over five years.
  • Compared with a year earlier, Net Shares Issued and Repurchased has declined for three straight quarters, with growth averaging 73.6% over the last eight quarters.
  • The best year-over-year quarter for Net Shares Issued and Repurchased over five years was Q4 2025 (growth of 266.2%); the worst was Q2 2026 (a decline of 93.9%).
  • Per Business Quant data, AMRX's Net Shares Issued and Repurchased in the three quarters before Q3 2026 was $42,000 (Q2 2026), $38,000 (Q1 2026) and $553,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -966.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -5.00 Mn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 4.00 Mn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -283.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Amneal Pharmaceuticals 7.10 Bn 6.33 Bn 334.12 Mn 436,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 436,000.00
Jun 30, 2026 42,000.00
Mar 31, 2026 38,000.00
Dec 31, 2025 553,000.00
Sep 30, 2025 653,000.00
Jun 30, 2025 685,000.00
Mar 31, 2025 69,000.00
Dec 31, 2024 151,000.00
Sep 30, 2024 617,000.00
Jun 30, 2024 358,000.00
Mar 31, 2024 28,000.00
Dec 31, 2023 43,000.00
Sep 30, 2023 408,000.00
Sep 30, 2022 423,000.00
Jun 30, 2022 128,000.00
Mar 31, 2022 111,000.00
Dec 31, 2021 19,000.00
Sep 30, 2021 153,000.00
Jun 30, 2021 5,000.00
Mar 31, 2021 676,000.00
API Access

Amneal Pharmaceuticals Net Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=AMRX&period=max&api_key=YOUR_API_KEY